FDAHealthOctober 13, 2025
Teva Pharmaceuticals USA, Inc — Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limi
⚠️ Subpotent drug; Clavulanate Potassium component
Is this relevant to me?
- Geography
- MS, OH, CA
- Source agency
- FDA
- Category
- Health
- Published
- October 13, 2025
Distributed in three (3) States: MS, OH, CA.
What's affected?
- Product
- Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.
- Lot code
- 100062316
Additional details
Lot # 100062316, Exp Date: 01/2026
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 4680 cartons.
Get Health recall alerts
Delivered to your inbox. Free. No account required.